We have located links that may give you full text access.
Recent Progress on Neutralizing Antibodies against Hepatitis B Virus and its Implications.
Infectious Disorders Drug Targets 2018 June 29
BACKGROUND: Hepatitis B virus (HBV) infection remains a global health problem. As "cure" for chronic hepatitis B is of current priority, hepatitis B immunoglobulin (HBIG) has been utilized for several decades to provide post-exposure prophylaxis. In recent years, a number of monoclonal antibodies (mAbs) targeting HBV have been developed and demonstrated with high affinity, specificity, and neutralizing potency.
OBJECTIVE: HBV neutralizing antibodies may play potentially significant role in the search for an HBV cure. In this review, we will summarize the recently progress in developing HBV-neutralizing antibodies, describe their characteristics and potential clinical applications.
RESULTS AND CONCLUSION: HBV neutralizing antibodies could be a promising alternative in the prevention and treatment of HBV infection. More importantly, global collaboration and coordinated approaches are thus needed to facilitate the development of novel therapies for HBV infection.
OBJECTIVE: HBV neutralizing antibodies may play potentially significant role in the search for an HBV cure. In this review, we will summarize the recently progress in developing HBV-neutralizing antibodies, describe their characteristics and potential clinical applications.
RESULTS AND CONCLUSION: HBV neutralizing antibodies could be a promising alternative in the prevention and treatment of HBV infection. More importantly, global collaboration and coordinated approaches are thus needed to facilitate the development of novel therapies for HBV infection.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app